US BROKER MOVES: CSGP upgraded at Jefferies; WMT downgraded at HSBC
SourceNewsquawk
SectionUS Equities
UPGRADES
- YETI Holdings (YETI) upgraded from Neutral to Buy at B Riley; PT USD 54
- Southern Co (SO) upgraded from Underweight to Equal-Weight at Wells Fargo; PT USD 96
- Southern Co (SO) upgraded from Neutral to Outperform at Mizuho Securities; PT USD 104
- Neptune Insurance (NP) upgraded from Underperform to Neutral at BofA; PT USD 23
- Healthcare Services (HCSG) upgraded from Market Perform to Outperform at William Blair
- Group 1 Automotive (GPI) upgraded from Neutral to Overweight at JPMorgan; PT USD 370
- Etsy (ETSY) upgraded from Equalweight to Overweight at Barclays
- CoStar (CSGP) upgraded from Hold to Buy at Jefferies; PT USD 67
DOWNGRADES
- Walmart (WMT) downgraded from Buy to Hold at HSBC; PT USD 131
- Teekay Tankers (TNK) downgraded from Buy to Hold at DNB Carnegie
- TechnipFMC (FTI) downgraded from Buy to Hold at HSBC; PT USD 62
- Reliance (RS) downgraded from Overweight to Neutral at JPMorgan; PT USD 330
- Reliance (RS) downgraded from Outperform to Market Perform at BMO; PT USD 320
- Molina (MOH) downgraded from Overweight to Equal-Weight at Wells Fargo; PT USD 141
- Mister Car Wash (MCW) downgraded from Outperform to Market Perform at Raymond James
- Coeur Mining (CDE) downgraded from Buy to Hold at Canaccord
- BorgWarner (BWA) downgraded from Neutral to Sell at UBS; PT USD 55
- Alight (ALIT) downgraded from Buy to Neutral at Citi; PT USD 1
INITIATIONS
- Terra Innovatum Global (NKLR) initiated at Buy at Canaccord; PT USD 10
- Satellogic (SATL) initiated at Overweight at Cantor; PT USD 7
- Pfizer (PFE) initiated at Underweight at Barclays
- Okyo Pharma (OKYO) initiated at Overweight at Piper Sandler; PT USD 7
- Merck & Co (MRK) initiated at Overweight at Barclays
- Gilead (GILD) initiated at Equal-Weight at Barclays
- General Electric Aerospace (GE) initiated at Overweight at Morgan Stanley; PT USD 425
- Eli Lilly (LLY) initiated at Overweight at Barclays
- Dauch Corp. (DCH) initiated at Buy at Jefferies; PT USD 10.35
- Bristol Myers (BMY) initiated at Overweight at Barclays
- Biogen (BIIB) initiated at Equal-Weight at Barclays
- Beam Therapeutics (BEAM) initiated at Buy at Canaccord; PT USD 74
- Affirm Holdings (AFRM) initiated at Neutral at Baird; PT USD 55
- AbbVie (ABBV) initiated at Overweight at Barclays